Robyn J. Medcraft
Royal Brisbane and Women's Hospital, The University of Queensland
Papers
2
Total Citations
46
H-Index
2
About
Robyn J. Medcraft is a leading clinical researcher in urological oncology, with a focused expertise in prostate cancer surgical outcomes. Her major contributions center on the comparative effectiveness of open versus robotic-assisted prostatectomy for localized disease. Medcraft was instrumental in designing and executing one of the first prospective, randomised trials directly comparing these surgical approaches, a landmark study published in 2012 (27 citations) that provided critical evidence on functional recovery, oncological control, and quality of life. Her subsequent 2013 progress report (19 citations) further detailed longitudinal patient outcomes, helping to shape surgical decision-making in Australia and beyond. By generating high-quality, randomised data in a field often dominated by observational studies, Medcraft’s work has directly informed clinical guidelines and patient counseling. Her research is notable for its rigorous methodology and patient-centered endpoints, addressing a key debate in prostate cancer management. With a career dedicated to evidence-based surgical innovation, Medcraft remains a vital voice in urological oncology, bridging the gap between technological advancement and proven patient benefit.
Research Focus
Key Achievements
Top Papers
- 1
- 2